title: Antibody responses of calves to Histophilus somni recombinant IbpA subunits.
abstract: Histophilus somni causes bovine pneumonia and septicemia, but protective immune responses are not well understood and immunodiagnostic methods are not well defined. We previously showed that antibody to a new virulence factor, IbpA, neutralizes cytotoxicity and immunization with a recombinant IbpA domain protects calves against experimental H. somni pneumonia. To further define immune responses to IbpA, we determined isotypic serum antibody responses to three IbpA domains (IbpA3, an N-terminal coiled coil region; IbpA5, a central region of 200 bp repeats and IbpA DR2, a C-terminal cytotoxic domain). ELISA was used to quantitate IgG1 or IgG2 antibodies to each of the IbpA subunits as well as H. somni whole cells (WCs) or culture supernatant (SUP). Calves experimentally infected with H. somni and monitored for up to 10 weeks had the least "0 time" (background) antibody levels to IbpA5, as well as the earliest and highest responses of greatest duration to the IbpA5 subunit. Responses of these calves were high to WC or SUP antigens but with higher "0 time" (background) antibody levels. We concluded that IbpA5 may be a useful immunodiagnostic antigen. Calves immunized with H. somni WC vaccine had antibody responses to WC antigens, but not to IbpA subunits before challenge. After challenge with H. somni, vaccinated calves had slight anamnestic responses to IbpA3 and IbpA5, but not to IbpA DR2. Since IbpA DR2 is a protective antigen, the data suggest the IbpA DR2 would be a useful addition to H. somni vaccines.
authors.affiliation: Department of Pathology, University of California, San Diego, San Diego, CA 92103, USA.
authors.forename: Kimberly L
authors.initials: KL
authors.lastname: Lo
authors.forename: Richard A
authors.initials: RA
authors.lastname: Kimball
authors.forename: Jason
authors.initials: J
authors.lastname: Lehmann
authors.forename: Laurel J
authors.initials: LJ
authors.lastname: Gershwin
authors.forename: Carolyn
authors.initials: C
authors.lastname: Worby
authors.forename: Lynette B
authors.initials: LB
authors.lastname: Corbeil
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D000917:Antibody Formation; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology / Q000378:metabolism; D002417:Cattle / Q000276:immunology*; D002418:Cattle Diseases / Q000276:immunology* / Q000382:microbiology; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D015661:Pasteurellaceae / Q000276:immunology* / Q000472:pathogenicity; D016871:Pasteurellaceae Infections / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D021122:Protein Subunits / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000378:metabolism; D011994:Recombinant Proteins / Q000276:immunology; D037521:Virulence Factors / Q000276:immunology / Q000378:metabolism
chemical_list: D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D007074:Immunoglobulin G; D021122:Protein Subunits; D011993:Recombinant Fusion Proteins; D011994:Recombinant Proteins; D037521:Virulence Factors